References
Triantafillidis J, Nasioulas G, Kosmidi P.Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies. Anticancer Res 2009; 29: 2727-2738
Lucas M. Inflammatory Bowel Disease as a Risk Factor for Colorectal Cancer. Dig Dis. 2010:619-624.
Thomas T, Abrams KA, Robinson RJ et al. Meta-analysis: Cancer risk of low grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007;25:657-668.
Odze R, Goldblum J, Noffsinger A et al. Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol 2002;379-386
Odze R, Tomaszewski J, Feldman M et al. Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology. Oncol Rep 2006;16:1123-1129.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berho, M., Allende, D. The Role of the Pathologist in the Diagnosis and Treatment of Dysplasia in Inflammatory Bowel Disease. J Gastrointest Surg 18, 1231–1233 (2014). https://doi.org/10.1007/s11605-014-2505-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-014-2505-5